![Image of UK B.1.1.7 variant SARS-CoV-2 virus particles (green), isolated from a patient sample](https://covid19briefings.com/wp-content/uploads/2021/04/covid-NIAID-UKB117-virus-particles-orange-51088469519_844171359a_k-sm-crop-cutline.jpg)
New Assay Allows for Customizable Testing of SARS-CoV-2 Variants Using PCR Technology
The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify these new variants. A new mutation panel may offer an alternative to viral genome sequencing for indicating the possible presence of these variants.